Bellerophon Therapeutics Inc
General ticker "BLPH" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $425.9K
Bellerophon Therapeutics Inc does not follow the US Stock Market performance with the rate: -28.5%.
Estimated limits based on current volatility of 8.8%: low 0.01$, high 0.02$
Factors to consider:
- Company pays dividends: last record date 2024-12-19, amount 0.02$ (Y666.67%)
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2022-12-31 to 2024-12-30
- 2022-12-31 to 2023-12-31 estimated range: [0.51$, 1.44$]
- 2023-12-31 to 2024-12-30 estimated range: [0.54$, 1.48$]
Financial Metrics affecting the BLPH estimates:
- Negative: Non-GAAP EPS, $ of -2.08 <= 0.10
- Negative: Operating profit margin, % of -100 <= 1.03
- Negative: negative Net income
- Negative: Operating cash flow per share per price, % of -67.18 <= 2.35
- Positive: Inventory ratio change, % of 0 <= 0
Short-term BLPH quotes
Long-term BLPH plot with estimates
Financial data
| YTD | 2020-12-31 | 2021-12-31 | 2022-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $26.28MM | $20.16MM | $22.38MM |
| Operating Income | $-26.28MM | $-20.16MM | $-22.38MM |
| Non-Operating Income | $-0.58MM | $0.60MM | $0.14MM |
| Interest Expense | $0.25MM | $0.01MM | $0.14MM |
| R&D Expense | $17.89MM | $13.02MM | $16.36MM |
| Income(Loss) | $-26.85MM | $-19.56MM | $-22.25MM |
| Taxes | $-2.12MM | $-1.80MM | $-2.42MM |
| Profit(Loss) | $-24.73MM | $-17.76MM | $-19.83MM |
| Stockholders Equity | $38.25MM | $21.62MM | $2.53MM |
| Assets | $50.24MM | $26.88MM | $7.93MM |
| Operating Cash Flow | $-19.88MM | $-22.82MM | $-17.77MM |
| Financing Cash Flow | $57.57MM | $0.00MM | $-0.04MM |
| Earnings Per Share* | $-3.17 | $-1.87 | $-2.08 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.